Anika Therapeutics
ANIK • NASDAQ
Anika Therapeutics is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Stephen D. Griffin, with a market cap of $204.0M.
Market Cap$204.0M
Employees357.0
CEOStephen D. Griffin
CountryUnited States of America
Healthcare
Medical - Devices
Next EarningsMay 8, 2026 · In 3 weeksQ1 2026
Financials
Anika Therapeutics FAQ
Common questions about Anika Therapeutics
Anika Therapeutics is scheduled to report earnings for Q1 2026 on May 8, 2026. Analysts estimate revenue of $28.1M.
Anika Therapeutics has approximately 357 employees.